Loading...
Raia Drogasil S.A.
RADLY•PNK
HealthcareMedical - Pharmaceuticals
$3.01
$0.52(20.88%)
Raia Drogasil S.A. (RADLY) Stock Overview
Explore Raia Drogasil S.A.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
14.40%
↑ 14.40%
Profit Growth
$0.71
↑ 13.53%
EPS Growth
$0.71
↑ 10.77%
Operating Margin
6.02%
↑ 13.78%
ROE
18.49%
↑ 13.53%
Dividend Yield
0.00%
↑ 18.27%
Analyst Recommendations data is not available for RADLYAnalyst Recommendations details for RADLY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
CEO
Mr. Renato Cepollina Raduan
Employees
66,275
Headquarters
Av. Corifeu de Azevedo Marques, 3097, São Paulo, SP
Founded
2016